Skip to main content

JPMORGAN CHASE & CO

Position in CCCC — C4 Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in CCCC

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$22,170,467
+$13,693,836 QoQ
Shares Held
4,747,424
+47.3% QoQ
Ownership
3.86%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in CCCC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. CCCC ranks #60 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CCCC

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,170,467 4,747,424
2026-03-31 $8,476,631 3,223,054
2025-12-31 $11,354 5,945
2025-09-30 $9,832 4,429
2025-06-30 $6,586 4,606
2025-03-31 $55,069 34,419
2024-12-31 $120,271 33,409
2024-09-30 $146,938 25,779
2024-06-30 $115,466 24,993
2024-03-31 $49 6
2023-12-31 $38,945 6,893
2023-09-30 $16,991 9,135
2023-06-30 $4,133 1,503
2023-03-31 $106,328 33,863
2022-12-31 $592,843 100,482
2022-09-30 $231,219 26,365
2022-06-30 $186,855 24,782
2022-03-31 $1,684,127 69,420
2021-12-31 $924,847 28,722
2021-09-30 $2,449,758 54,829
2021-06-30 $625,721 16,536
2021-03-31 $229,743 6,211
2020-12-31 $158,593 4,787